Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 26 of 35

COMPLETED NA

Acupuncture for Sleep Disruption in Cancer Survivors

NCT01162018

TERMINATED NA

Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population

NCT01322971

COMPLETED Phase 2

Management of Insomnia in Breast Cancer Patients

NCT01011218

COMPLETED Phase 1

A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects

NCT01591148

COMPLETED

Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates

NCT01357369

COMPLETED NA

Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits

NCT01466751

TERMINATED Phase 2

Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

NCT01401322

TERMINATED NA

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

NCT01284504

TERMINATED Phase 2

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

NCT01151761

COMPLETED Phase 1

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

NCT01290484

COMPLETED

Stanford Universities: The Stanford HIV Aging Cohort

NCT01401348

TERMINATED Phase 1

Imaging and Biomarkers of Hypoxia in Solid Tumors

NCT01123005

TERMINATED NA

The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses

NCT01406795

TERMINATED Phase 1

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

NCT01187446

TERMINATED NA

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss

NCT01325805

COMPLETED NA

Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human Volunteers

NCT01006707

COMPLETED NA

Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery

NCT01245595

COMPLETED

Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Cesarean Delivery

NCT01416454

COMPLETED NA

Promoting Healthy Lifestyles Using Mobile Phones

NCT01516411

COMPLETED Early Phase 1

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2

NCT01383135

TERMINATED

A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity

NCT01335113

COMPLETED NA

Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents

NCT01217840

COMPLETED NA

Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)

NCT01507948

COMPLETED NA

Environmental Strategies & Behavior Change to Reduce Overeating in Obese Children

NCT01221220

COMPLETED NA

An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism

NCT01400269

COMPLETED Phase 4

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

NCT01831934

COMPLETED

Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk

NCT01423201

COMPLETED Phase 4

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

NCT01911065

COMPLETED

Continuous Glucose Monitor Use in School

NCT01364766

TERMINATED Phase 2

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

NCT01450683

TERMINATED NA

Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract

NCT00721539

TERMINATED

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

NCT01163526

COMPLETED NA

A National Study of the Chronic Disease Self-Management Program

NCT01845857

COMPLETED

Understanding and Diagnosing Allergic Disease in Twins

NCT01613885

COMPLETED Phase 1

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817

COMPLETED

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

NCT01182155

COMPLETED Phase 1

Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

NCT01114282

TERMINATED NA

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

NCT01188486

COMPLETED NA

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

NCT01186276

COMPLETED NA

Pivotal Response Group Treatment for Parents of Young Children With Autism

NCT01881750

COMPLETED NA

Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?

NCT02007577

COMPLETED

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

NCT01200875

COMPLETED Phase 3

Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS)

NCT01171794

COMPLETED Phase 2

Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation

NCT01186250

COMPLETED

Endogenous Endophthalmitis in the Inpatient Setting

NCT01323868

COMPLETED Phase 4

A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

NCT01305252

COMPLETED

Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

NCT01165775

COMPLETED

The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging

NCT01172041

TERMINATED

Cyberknife Radiosurgery and Quality of Life

NCT01163539

TERMINATED NA

Radiosurgical Neuromodulation for Refractory Depression

NCT01403441

← Previous Page 26 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.